SOAT1 and rheumatoid arthritis: Low dose MTX, the gold standard RA treatment, broadly inhibits several immune pathways involved in purine and pyrimidine synthesis, transmethylation reactions, translocation of NF-κB to the nucleus, signaling via the Janus kinase (JAK)–signal transducer and activator of transcription (STAT) pathway and nitric oxide production [138].